Phase 3 Clinical Trials – Page 4

AstraZeneca’s Truqap Achieves Phase III Success in Prostate Cancer, Reviving Hopes After Breast Cancer Setback

11 months ago talkbio0Tagged Antiandrogen therapy, AstraZeneca, Malignant neoplasm of prostate, Metastatic to, Phase 3 Clinical Trials, Progression-Free Survival, PTEN-deficient, Radiographic, rPFS, Truqap

AstraZeneca, Truqap, prostate cancer, Phase III trial, PTEN-deficient metastatic hormone-sensitive prostate cancer, radiographic progression-free survival (rPFS), abiraterone, androgen deprivation therapy (ADT).

Axsome Therapeutics Narcolepsy Drug AXS-12 Achieves Phase III Success, Paving Way for US FDA Filing

11 months ago talkbio0Tagged AXS-12, Axsome, Encore, File (record), Narcolepsy, NDA, Phase 3 Clinical Trials, United States Food and Drug Administration

Axsome Therapeutics, AXS-12, narcolepsy, Phase III trial, ENCORE trial, FDA filing, NDA

Sanofi’s Rilzabrutinib Shows Promising Results in Phase III Trial for Immune Thrombocytopenia (ITP)

12 months ago talkbio0Tagged Autoimmune thrombocytopenia, BTK inhibitor, Clinical Research, Phase 3 Clinical Trials, Rilzabrutinib, sanofi

Rilzabrutinib, BTK inhibitor, Immune Thrombocytopenia (ITP), Phase III trial, Sanofi, LUNA 3 study

Otsuka Seeks Accelerated Approval for Sibeprenlimab in IgA Nephropathy Following Positive Phase III Interim Results

1 year ago talkbio0Tagged Accelerated, Antibodies, Approved, Autoimmune Diseases, IGA Glomerulonephritis, Kidney Diseases, Otsuka, Phase 3 Clinical Trials, Sibeprenlimab, TNFSF13 protein, human, United States Food and Drug Administration

Otsuka, sibeprenlimab, IgA nephropathy, Phase III trial, accelerated approval, FDA, kidney disease, autoimmune disease, APRIL antibody.

Vertex’s Non-Opioid Pain Drug, Suzetrigine (VX-548), Shows Promising Results in Phase III Trials, Aiming for FDA Approval

1 year ago talkbio0Tagged Acute onset pain, Approved, non-opioid pain drug, Opioids, Phase 3 Clinical Trials, Suzetrigine, United States Food and Drug Administration, VX-548

Non-opioid pain drug, Suzetrigine (VX-548), Vertex Pharmaceuticals, Phase III trials, acute pain, FDA approval, opioid alternative

Lilly’s Omvoh Outperforms J&J’s Stelara in Phase III Crohn’s Disease Trial

1 year ago talkbio0Tagged Crohn 's disease, Eli, Eli Lilly, Inflammatory Bowel Diseases, mirikizumab, Phase 3 Clinical Trials, Stelara, ustekinumab

Omvoh (mirikizumab), Stelara (ustekinumab), Crohn’s disease, Phase III trial, Inflammatory bowel disease (IBD), Eli Lilly, Johnson & Johnson

Scholar Rock’s Stock Skyrockets 300% Following Successful Phase III Trial of Apitegromab for Spinal Muscular Atrophy

1 year ago talkbio0Tagged apitegromab, Biologics License Application, MAA, Phase 3 Clinical Trials, Scholar Rock, SMA, Spinal Muscular Atrophy, Stock Surge

Scholar Rock, Spinal Muscular Atrophy (SMA), Apitegromab, Phase III Trial, Stock Surge, Biologics License Application (BLA), Marketing Authorisation Application (MAA)